vTv Therapeutics Inc. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
vTv Therapeutics Inc. (VTVT) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $4.20 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2024-03-13
- vTv Therapeutics Inc. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $4.20M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|
| 2023-12-31 | $4.20M 10-K · filed 2024-03-13 |